Nephrotoxicity Related to New Therapeutic Compounds
@article{Szeto2005NephrotoxicityRT, title={Nephrotoxicity Related to New Therapeutic Compounds}, author={Cheuk Chun Szeto and Kai Ming Chow}, journal={Renal Failure}, year={2005}, volume={27}, pages={329 - 333} }
Toxic nephropathy is an important cause of reversible renal injury. This article focuses on the nephrotoxicity of several new therapeutic compounds. Selective cyclooxygenase-2 inhibitor is associated with sodium retention, hypertension, ankle edema, and acute renal failure. The incidence of renal complication is similar to conventional nonsteroidal anti-inflammatory drugs. Bisphosphonates, especially when used in high dose for prolonged duration, can cause toxic acute tubular necrosis and renal…
27 Citations
Toxic Nephropathy Due to Drugs and Poisons
- Medicine, Biology
- 2010
awareness of the range of toxins on the one hand, and simple measures such as adequate prehydration of the patient and drug monitoring, on the other hand, may be sufficient to avoid drug-induced ARF or minimize its clinical severity in susceptible patients.
A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome.
- MedicineEndocrine journal
- 2012
This is the first report of zoledronate-induced interstitial nephritis-Fanconi syndrome and indicates the close monitoring of renal function to avoid potential nephrotoxicity of zolingronate.
Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies
- MedicineVirchows Archiv
- 2007
It is concluded that acute interstitial nephritis and consecutive acute renal failure is a relevant side effect of atazanavir and tenofovir therapy in HIV-positive patients.
Treatment of renal sarcoidosis: is there a guideline? Overview of the different treatment options.
- MedicineNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- 2014
An overview of the different treatment options for sarcoidosis is presented to promote a more uniform and scrutinized approach of this disease.
Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells.
- Biology, MedicineMolecular pharmaceutics
- 2014
An in vitro model with embryonic stem-cell-derived human renal proximal tubular-like cells that uses the expression of interleukin (IL)-6 and IL-8 as end points is developed that predicts proximaltubular toxicity in humans with high accuracy.
An in vitro method for the prediction of renal proximal tubular toxicity in humans
- Biology, Medicine
- 2013
The data suggest that the model would allow the prediction of drug-induced proximal tubular toxicity at early pre-clinical stages during drug development, and it would be expected that in ∼76%–85% of the cases where compounds were predicted as positives or negatives the predictions would be correct.
Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models.
- Biology, MedicineMolecular pharmaceutics
- 2014
Current approaches on the development of three-dimensional and microfluidic models and recently developed stem cell based approaches are reviewed, showing that high predictivity can be obtained by using primary or stem cell derived human renal cells in combination with appropriate end points.
MicroRNA-34c-3p is an early predictive biomarker for doxorubicin-induced glomerular injury progression in male Sprague-Dawley rats
- Medicine, Biology
- 2014
Urinary miR-34c-3p elevations were predictive of histopathologic injury progression and outperformed the traditional renal biomarkers, serum creatinine and blood urea nitrogen, which did not increase with treatment.
Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
- Medicine, BiologyTherapeutics and clinical risk management
- 2008
Ibandronate is a highly potent bisphosphonate available in both intravenous and oral preparations that has been shown in clinical trials to be effective in reducing skeletal complications and also significantly improve quality of life up to 96 weeks.
References
SHOWING 1-10 OF 24 REFERENCES
Toxic acute tubular necrosis following treatment with zoledronate (Zometa).
- MedicineKidney international
- 2003
The close temporal relationship between zoledronate administration and the onset of renal failure and the partial recovery of renal function following drug withdrawal strongly implicate this important and widely used agent in the development of toxic ATN.
Crystalluria and Urinary Tract Abnormalities Associated with Indinavir
- MedicineAnnals of Internal Medicine
- 1997
A spectrum of urinary tract findings in patients treated with indinavir is reported, most common is asymptomatic crystalluria associated with dysuria, urgency, back and flank pain, and renal colic, while some patients with back or flank pain had radiographic evidence of renal parenchymal defects.
Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.
- Biology, MedicineHuman pathology
- 2001
It is concluded that adefovir-induced nephrotoxicity is mediated by depletion of mt DNA from proximal tubular cells through inhibition of mtDNA replication, which may serve as a prototype for other forms of renal toxicity caused by reverse transcriptase inhibitors.
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.
- MedicineAmerican journal of therapeutics
- 2000
It is concluded that celecoxib is well tolerated by patients who may be at risk for NSAID-induced renal toxicity, such as the elderly and those with hypertension or preexisting chronic heart disease, and there was no evidence of drug-drug interactions between cele Coxib and concomitant angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, calcium channel blockers, or diuretics.
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.
- MedicineJournal of the American Society of Nephrology : JASN
- 2001
The temporal association between pamidronate therapy and the development of renal insufficiency, the use of escalating doses that exceed recommended levels, and the distinctive pattern of glomerular andtubular injury strongly suggest a mechanism of drug-associated podocyte and tubular toxicity.
Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature.
- Medicine, BiologyJournal of the American Society of Nephrology : JASN
- 1997
Two cases of IVIG-induced ARF are described, and all reported cases are analyzed to assess the probable mechanism of renal injury.
Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.
- MedicineAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2000
The main findings were the high proportion of subjects with crystalluria and the relatively high frequency of crystalluria observed consistently throughout and abnormal urinalysis results were noted frequently during the first year of treatment with indinavir.
Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin.
- Medicine, BiologyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2002
A kidney allograft recipient who developed anemia due to parvovirus B19induced erythroaplasia and Therapeutic intervention with IV Ig resulted in acute graft failure requiring transient hemodialysis.
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
- Medicine, BiologyThe Journal of pharmacology and experimental therapeutics
- 1999
The data suggest that acute sodium retention by nonsteroidal anti-inflammatory drugs in healthy elderly subjects is mediated by the inhibition of Cox-2, whereas depression of GFR is due to inhibition ofcox-1.